Nucleic acid encapsulation and decapsulation method and nucleic acid storage microfluidic chip
By forming a metal organic frame encapsulation layer on nanospheres and encapsulating and de-encapsulating using microfluidic chips, the high cost and inefficiency of DNA data storage are solved, and fast and secure DNA data protection and reading are achieved, improving the efficiency of improving DNA data The practicality and security of DNA storage.
Patent Information
- Application Number
- CN202210414827.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-20
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-04-20
AI Technical Summary
The existing DNA data storage technology has high storage costs, low reading and writing efficiency, and long-term storage and access of DNA data. Traditional packaging methods require highly toxic acid dissolution, which poses security risks and low storage efficiency.
Using nanospheres as carriers, the metal organic frame (MOFs) encapsulation layer is formed by reacting organic ligands and metal ions to quickly protect nucleic acid fragments, and encapsulation and de-encapsulation are achieved through microfluidic chips, and the acid reagent-sensitive ZIFs material is used to achieve no-free De-encapsulation, simplifying operation and improving security.
It realizes rapid and secure encapsulation and de-encapsulation of DNA, reduces the time to generate protective layers, avoids the use of highly toxic substances, improves the practicality and security of data storage, and ensures the integrity and long-term storage of DNA information. .
Smart Images

Figure CN114717227B_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of DNA data storage, and in particular to a method for packaging and depackaging nucleic acids and a nucleic acid storage microfluidic chip. Background Art
[0002] With the rapid development of contemporary information technology, the content of data information is growing exponentially, and this growth trend will soon exceed the bearing capacity of existing storage media. In order to meet the rapidly growing storage needs of data, it is urgent to find a new data storage medium. DNA, as an emerging data information carrier, has the advantages of ultra-high storage density, ultra-long storage time, low energy maintenance, and environmental friendliness compared to traditional electronic information storage. These excellent properties make DNA an ideal choice for information storage and a hot spot for global research.
[0003] Zielinski et al. used fountain codes to achieve robust and efficient DNA data storage, and can store up to 215PB of data in 1g of DNA, showing a beautiful blueprint for DNA data storage. However, DNA data storage technology is a new technology that is deeply cross-disciplinary in development, such as synthetic biology and information technology, and there are still many challenges to overcome. For example, the high storage cost, low read and write efficiency, and the decentralized functions of long-term preservation, access, and indexing of DNA data, as well as the complex and time-consuming storage steps make DNA storage inefficient and difficult to be widely used. In recent years, with the development of coding technology, the reduction of DNA synthesis costs and sequencing costs, the long-term preservation of DNA data storage has become one of the most critical issues in DNA data storage. The physical and chemical integrity of DNA molecules determines the integrity of digital information, so the development of effective DNA data protection methods is crucial for DNA data storage.
[0004] DNA molecules are essentially biological molecules. Natural unprotected DNA is easily hydrolyzed, alkylated and oxidized, causing damage to the DNA sequence and loss of stored information. Currently available preservation methods include aqueous solutions, dehydration, low temperature, stabilizers, and encapsulation. Among these preservation techniques, encapsulating DNA in a silica shell is considered to be the most durable preservation method, with a half-life of nearly 2000 years at a temperature of 9.4°C. However, preserving DNA in this way requires four days to form a silica shell to protect the DNA, and when reading, highly toxic hydrofluoric acid is needed to dissolve the silica shell to release the DNA. Therefore, developing a faster and safer DNA storage method is crucial to accelerating the industrial application of DNA as a data storage medium. Summary of the invention
[0005] The present application aims to solve at least one of the technical problems existing in the prior art. To this end, the present application proposes a faster and safer method for packaging and depackaging nucleic acids that can be used for DNA storage and a nucleic acid storage microfluidic chip.
[0006] In a first aspect of the present application, a method for encapsulating nucleic acids is provided, which comprises the following steps: mixing an organic ligand, a metal ion and a nanosphere having at least one nucleic acid fragment fixed on its surface, wherein the organic ligand and the metal ion react to produce a metal organic framework and form an encapsulation layer on the surface of the nanosphere to obtain an encapsulated nanosphere.
[0007] The packaging method according to the embodiment of the present application has at least the following beneficial effects:
[0008] The present application uses nanospheres as carriers of nucleic acid fragments, encapsulates metal-organic frameworks through organic ligands and metal ions, and quickly forms an encapsulation layer on the surface of the carrier, thereby protecting the nucleic acid fragments encapsulated therein, and has good protection against free radicals, ultraviolet rays, etc. The entire encapsulation process is time-saving and simple to operate, and in the subsequent decapsulation process, there is no need to use highly toxic substances to treat the encapsulation layer, making the entire encapsulation and decapsulation process safer.
[0009] Among them, metal organic framework refers to Metal Organic Frameworks (MOFs), which are usually three-dimensional materials self-assembled with metal ions as connection points and organic ligands as frameworks. They have the characteristics of large specific surface area, adjustable pore size, excellent thermal stability and chemical stability, and high biocompatibility. In the embodiment of the present application, the encapsulation layer (protective layer) of the metal organic framework is formed by self-assembly of raw materials of organic ligands and metal ions on the surface of nanospheres, thereby greatly compressing the time for generating the protective layer while ensuring its preservation effect.
[0010] In some embodiments of the present application, the metal ion is a transition metal ion, the organic ligand is an imidazole ligand, and the metal organic framework is ZIFs. ZIFs (Zeolitic Imidazolate Frameworks) materials are a class of MOFs with a structure similar to aluminosilicate zeolite molecular sieves, which are composed of transition metals coordinated with imidazoles and their derivatives. ZIFs have excellent crystal growth and molding characteristics and can be rapidly synthesized at room temperature, in aqueous or organic phases. In the embodiments of the present application, such ZIFs are preferably used as encapsulation protective layers to further simplify reaction conditions and compress reaction time.
[0011] In some embodiments of the present application, the transition metal ion is selected from at least one of zinc ion and cobalt ion.
[0012] In some embodiments of the present application, the imidazole ligand is selected from at least one of imidazole, 2-methylimidazole, 2-ethylimidazole, 2-nitroimidazole, 2-formylimidazole, 4,5-dichloroimidazole, benzimidazole, and 5-chlorobenzimidazole.
[0013] The microstructure of ZIFs further depends on the imidazole ligands, transition metal ions and the solvent during the reaction process. According to the differences in the above raw materials and conditions, ZIFs further include but are not limited to ZIF-2, ZIF-3, ZIF-4, ZIF-8, ZIF-10, ZIF-11, ZIF-14, ZIF-20, ZIF-21, ZIF-23, ZIF-60, ZIF-62, ZIF-64, ZIF-65, ZIF-67, ZIF-69, ZIF-70, ZIF-71, ZIF-73, ZIF-74, ZIF-90, etc.
[0014] In some embodiments of the present application, the imidazole ligand is 2-methylimidazole, and the transition metal ion is zinc ion. ZIF-8 formed with zinc ion and 2-methylimidazole is the most representative one in ZIFs materials. ZIF-8 is stable in water and aqueous sodium hydroxide solution, but will decompose very quickly under acidic conditions. Therefore, when ZIF-8 is used as an encapsulation layer, the pH conditions of the encapsulated nanospheres can be changed to achieve rapid decapsulation. Other ZIFs such as ZIF-90, ZIF-67, etc., which are also sensitive to acidic environments, can also be used as alternatives to ZIF-8.
[0015] In some embodiments of the present application, the concentration of the imidazole ligand is 1 to 500 mM, and the concentration of the transition metal ion is 1 to 100 mM.
[0016] In some embodiments of the present application, the concentration of the imidazole ligand is 50-400 mM, and the concentration of the transition metal ion is 20-80 mM.
[0017] In some embodiments of the present application, the concentration of the imidazole ligand is 100-200 mM, and the concentration of the transition metal ion is 30-50 mM.
[0018] The method of forming an encapsulation layer by mixed reaction of organic ligands, metal ions and nanospheres can adopt an optional synthesis method of MOFs materials that does not affect the properties of the nucleic acid fragments fixed therein. Taking ZIFs materials as an example, it includes solvent thermal method, room temperature method, electrochemical method, mechanochemical method, ultrasonic chemical method, microwave assisted method, microfluidic method and the like. In the embodiment of the present application, the mixed reaction method preferably uses microfluidics to control the process of forming the encapsulation layer. For example, the morphology and size of the encapsulation layer can be adjusted by controlling the reaction temperature, the ratio and flow rate of various raw materials, etc., so as to obtain a better encapsulation effect.
[0019] In some embodiments of the present application, organic ligands, metal ions and nanospheres are distributed in a spiral microchannel for mixed reaction. The spiral microchannel provides an appropriate shear force for the organic ligands, metal ions and nanospheres therein to improve the mixing effect in the microchannel, thereby making the encapsulation layer more uniform and providing better protection for the nucleic acid fragments encapsulated therein.
[0020] In some embodiments of the present application, the microchannel is a bidirectional spiral type. By providing a bidirectional spiral microchannel, a stronger lateral shearing effect is provided for the raw materials therein, so that the internal mixing is more intense and uniform, and thus the packaging effect and the resulting preservation effect are better.
[0021] In some embodiments of the present application, the nucleic acid fragment is fixed to the nanosphere by any of electrostatic adsorption, chemical bonding, and biotin-avidin. The chemical bonding method includes but is not limited to the bonding between amino and carboxyl groups, the bonding between metal and sulfhydryl groups, the bonding between amino and aldehyde groups, and the coordination bond between metal and nucleic acid.
[0022] In some embodiments of the present application, nanosphere refers to a microsphere with a nanometer scale size, which is preferably a silicon dioxide microsphere, such as a monodisperse spherical silica, which has a large specific surface area, good dispersibility, and good optical properties and stability. Use as a carrier can fix more nucleic acid fragments to increase data carrying capacity, and good dispersibility can ensure that the metal organic framework can self-assemble to form an encapsulation layer on each nanosphere surface during the encapsulation process, avoiding aggregation to affect encapsulation and protection. In addition, the parameters of the nanospheres fixed with different nucleic acid fragments are controlled as index conditions in the subsequent reading process by means such as the particle size and fluorescent labeling modification of the nanosphere itself, so as to perform directional reading. For example, the nanospheres after encapsulation are sorted by flow cytometry, and the nanospheres of specific particle size and fluorescent labeling are selected to de-encapsulate and read data, thereby avoiding the defect of needing whole library access.
[0023] The second aspect of the present application provides encapsulated nanospheres obtained according to the above encapsulation method. The encapsulated nanospheres obtained by the above method can provide good protection for the nucleic acid fragments therein, resist the damage of the external harsh environment such as ultraviolet rays and free radicals, ensure the integrity of the nucleic acid fragments, and also protect the integrity of the data information, so that they can be used as data storage media.
[0024] In some embodiments of the present application, the encapsulated nanosphere includes a nanosphere and an encapsulation layer wrapped around the nanosphere as a shell, and at least one nucleic acid fragment is fixed in the encapsulation layer and on the surface of the nanosphere.
[0025] In some embodiments of the present application, the nucleic acid fragment stores data information in a specific coding manner, such as by direct conversion, linear block code, fountain code, convolutional code, etc. The nucleic acid fragment can be DNA or RNA, and for the convenience and repeatability of subsequent reading, the nucleic acid fragment is preferably double-stranded DNA.
[0026] The third aspect of the present application provides a method for decapsulating nucleic acid, which comprises the following steps: mixing a decapsulation reagent with the aforementioned encapsulated nanospheres for reaction, removing the encapsulation layer, and obtaining decapsulated nanospheres.
[0027] By utilizing the degradable characteristics of the metal organic framework material, the nanospheres are released from the encapsulation layer through the use of an optional reagent capable of destroying the coordination bonds, and the nucleic acid fragments fixed thereon are further processed.
[0028] In some embodiments of the present application, the decapsulation agent is an acidic agent. For some ZIFs materials, they have strong stability under neutral and alkaline conditions, but are sensitive to acidic conditions, such as slightly acidic conditions. Therefore, the acid-base environment on the surface of the encapsulated nanospheres can be changed by mixing with acidic agents to achieve the purpose of quickly removing the encapsulation layer. It is understandable that the acidic agent should not damage the nucleic acid fragments fixed on the nanospheres to avoid the loss or damage of the stored data information; nor should it have the potential hazards of toxicity, flammability, and explosion.
[0029] In some embodiments of the present application, the acidic reagent is an acidic buffer. Since the ZIFs material is sensitive to acidity, it is preferred to use an acidic buffer as a decapsulation reagent to avoid significant pH changes after removing the encapsulation layer that affect the stability of the nucleic acid fragment while ensuring safety.
[0030] In some embodiments of the present application, the acidic reagent is a citrate buffer solution, and the pH of the citrate buffer solution is less than 7.
[0031] In some embodiments of the present application, the pH of the citrate buffer solution is 4-5.
[0032] The embodiments of the present application also provide a method for extracting nucleic acid, which includes the following steps: taking an extraction reagent and mixing it with the aforementioned decapsulated nanospheres to react, freeing at least part of the nucleic acid fragments from the decapsulated nanospheres, and separating them.
[0033] The extraction reagent refers to any reagent that can denature the nucleic acid fragments on the decapsulated nanospheres, thereby releasing at least part of the single-stranded nucleic acids, such as NaOH, formamide, etc., among which NaOH can completely denature DNA under most conditions and is the most effective choice for the extraction reagent.
[0034] In the above method, a single-stranded DNA is obtained by removing the encapsulation layer and chemically denaturing it, and then amplified by PCR or other methods for high-throughput sequencing. After sequencing, the sequence is decoded to obtain data information. The remaining single-stranded DNA on the nanoball as the master can be annealed and extended by polymerase reaction to restore the original data, realizing a closed DNA data storage chain of write-read-recovery, and can be read losslessly multiple times, avoiding the damage caused by whole library access based on PCR method.
[0035] In a fourth aspect of the present application, a nucleic acid storage microfluidic chip is provided, the nucleic acid storage microfluidic chip comprising an encapsulation layer generating unit, the encapsulation layer generating unit is used to encapsulate nanospheres, at least one nucleic acid fragment is fixed on the surface of the nanospheres, and the encapsulation layer generating unit comprises:
[0036] An encapsulation inlet, which is used to inject encapsulation reagents and nanospheres;
[0037] An encapsulation channel, which is connected to the encapsulation inlet and is used for allowing the nanospheres to react with the encapsulation reagent, thereby forming an encapsulation layer on the surface of the nanospheres to obtain encapsulated nanospheres;
[0038] The encapsulation outlet is connected to the encapsulation flow channel and is used to output the encapsulated nanospheres.
[0039] The nucleic acid storage microfluidic chip according to the embodiment of the present application has at least the following beneficial effects:
[0040] The nucleic acid storage microfluidic chip provided in the embodiment of the present application mixes the encapsulation reagent with the nanospheres through a microfluidic method, thereby forming an encapsulation layer on the surface of the nanospheres to complete rapid encapsulation.
[0041] In some embodiments of the present application, the encapsulation channel is spiral-shaped. Using the spiral channel as a reaction channel can provide effective shear force, so that the encapsulation reagent and the nanospheres are mixed more evenly, the encapsulation effect is improved, and the nucleic acid fragments therein are protected more efficiently.
[0042] In some embodiments of the present application, the encapsulation channel includes at least one bidirectional helical channel. Using the bidirectional helical channel as a reaction channel, the lateral shear force during the reaction is stronger, the mixing of the encapsulation reagent and the nanospheres is more thorough, and the encapsulation layer of the metal organic framework formed by self-assembly is more uniform.
[0043] In some embodiments of the present application, the encapsulated flow channel includes a plurality of interconnected bidirectional spiral flow channels.
[0044] In some embodiments of the present application, the nucleic acid storage microfluidic chip further includes an encapsulation layer removal unit, which is used to remove the encapsulation layer on the surface of the encapsulated nanospheres, and the encapsulation layer removal unit includes:
[0045] A decapsulation inlet, which is used to inject decapsulation reagents and encapsulated nanospheres;
[0046] A decapsulation channel, which is connected to the decapsulation inlet and is used for allowing the encapsulated nanospheres to react with the decapsulation reagent, thereby removing the encapsulation layer on the surface of the encapsulated nanospheres to obtain decapsulated nanospheres;
[0047] The decapsulation outlet is connected to the decapsulation flow channel and is used for outputting the decapsulated nanospheres.
[0048] In the nucleic acid storage microfluidic chip, the two functions of encapsulation and decapsulation are integrated by setting a decapsulation part. Nanomaterial-encapsulated nanospheres can be quickly generated in the chip to achieve a lasting data protection effect. When data needs to be obtained, the encapsulation layer can be quickly removed in the same chip at the same time.
[0049] In some embodiments of the present application, the depackaging flow channel is a serpentine flow channel.
[0050] In some embodiments of the present application, the nucleic acid storage microfluidic chip further includes a nucleic acid extraction unit, which is used to extract nucleic acid fragments from the decapsulated nanospheres, and the nucleic acid extraction unit includes:
[0051] An extraction inlet, the extraction inlet is used to inject decapsulated nanospheres and extraction reagents;
[0052] An extraction channel, the extraction channel is connected to the extraction inlet, and is used for the decapsulated nanospheres to react with the extraction reagent, so that the nucleic acid fragments are released from the decapsulated nanospheres;
[0053] The extraction outlet is used to collect the released nucleic acid fragments.
[0054] By further adding a nucleic acid extraction unit to the nucleic acid storage microfluidic chip, the three functions of encapsulation, decapsulation and extraction are integrated, so that rapid encapsulation protection and rapid data extraction of nanospheres storing nucleic acid data can be achieved in the same microfluidic chip.
[0055] In some embodiments of the present application, the extraction channel is spiral.
[0056] In some embodiments of the present application, the extraction channel includes at least one bidirectional spiral channel.
[0057] In some embodiments of the present application, the extraction channel includes a plurality of interconnected bidirectional spiral flow channels.
[0058] In some embodiments of the present application, the width of the encapsulation channel, the decapsulation channel, and the extraction channel is 1 to 2 mm, and the height is 0.01 to 0.1 mm.
[0059] In some embodiments of the present application, the encapsulation inlet, the decapsulation inlet, and the extraction inlet are each independently provided with a plurality of injection ports.
[0060] The sixth aspect of the present application provides the application of the aforementioned nucleic acid storage microfluidic chip in DNA data storage and reading.
[0061] In the embodiment of the present application, by the functional integrated microfluidic chip, the protective layer encapsulation of DNA nanoballs, the removal of the protective layer and the extraction of DNA data can be completed within 15min using encapsulation, decapsulation and extraction methods. After experimental verification, the generated encapsulation layer has a good protective effect on ultraviolet rays and free radicals, and the complete recovery of DNA information can be guaranteed. DNA data storage can be quickly and effectively preserved by this method, and when information needs to be extracted, the extraction of DNA data can be quickly completed on the same chip. The whole process is short in time consumption, simple in operation, low in cost and functionally integrated, which greatly increases the practicality of DNA information storage.
[0062] Additional aspects and advantages of the present application will be given in part in the description below, and in part will become apparent from the description below, or will be learned through the practice of the present application. BRIEF DESCRIPTION OF THE DRAWINGS
[0063] Figure 1 It is a structural schematic diagram of a nucleic acid storage microfluidic chip provided in an embodiment of the present application.
[0064] Figure 2 Schematic diagram of metal organic framework material (ZIF-8) encapsulation of nanospheres in Example 2. A and B are electron microscope morphology characterization diagrams of encapsulation directly in a centrifuge tube and in a microfluidic chip in Example 1 under the same conditions, respectively, and C is a statistical result of the thickness of the nanospheres before and after the encapsulation layer is formed in the microfluidic chip.
[0065] Figure 3 A to C in the middle are the surface morphologies of the nanospheres before encapsulation, after encapsulation of ZIF-8, and after de-encapsulation and demineralization.
[0066] Figure 4 These are the test results of the protection performance of the DNA nanospheres against ultraviolet rays and free radicals after being protected by the encapsulation layer in Example 4, where A is the ultraviolet (UV) test result and B is the free radical test result.
[0067] Figure 5 This is the lossless access process of DNA data fixed on microspheres in Example 5. A is a schematic diagram of a method for accessing encapsulated DNA nanospheres, and B is a qPCR quantitative curve graph of 10 accesses to DNA data.
[0068] Figure numerals: nucleic acid storage microfluidic chip 1, encapsulation layer generating unit 100, encapsulation inlet 110, first injection port 111, second injection port 112, third injection port 113, encapsulation channel 120, encapsulation outlet 130, encapsulation layer removing unit 200, de-encapsulation inlet 210, fourth injection port 211, fifth injection port 212, sixth injection port 213, de-encapsulation channel 220, de-encapsulation outlet 230, nucleic acid extraction unit 300, extraction inlet 310, seventh injection port 311, eighth injection port 312, extraction channel 320, extraction outlet 330. DETAILED DESCRIPTION
[0069] The following will clearly and completely describe the concept of the present application and the technical effects produced in combination with the embodiments, so as to fully understand the purpose, features and effects of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of them. Based on the embodiments of the present application, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present application.
[0070] The embodiments of the present application are described in detail below. The described embodiments are exemplary and are only used to explain the present application, and should not be understood as limiting the present application.
[0071] In the description of this application, "several" means more than one, "more" means more than two, "greater than", "less than", "exceed", etc. are understood to exclude the number itself, and "above", "below", "within", etc. are understood to include the number itself. If there is a description of "first" or "second", it is only used for the purpose of distinguishing technical features, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features or implicitly indicating the order of the indicated technical features.
[0072] In the description of the present application, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials, or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present application. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials, or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.
[0073] refer to Figure 1, shows the structure of the nucleic acid storage microfluidic chip in the embodiment of the present application, the nucleic acid storage microfluidic chip 1 includes an encapsulation layer generating part 100, the encapsulation layer generating part 100 includes an encapsulation inlet 110, an encapsulation flow channel 120 and an encapsulation outlet 130, the three are interconnected, the encapsulation reagent and the nanosphere are injected from the encapsulation inlet 110, and then flow through the encapsulation flow channel 120 under pressure for full mixing, the raw materials in the encapsulation reagent self-assemble on the surface of the nanosphere to form an encapsulation layer, and the encapsulated nanosphere is obtained, and finally discharged from the encapsulation outlet 130. In some specific embodiments, the encapsulation flow channel 120 is spiral, and the spiral flow channel gives the fluid therein a stronger shear force, so that the encapsulation reagent and the nanosphere therein can be mixed more evenly, so that the protective effect of the encapsulation layer formed on the surface of the nanosphere is better. In some preferred embodiments, the encapsulation flow channel 120 is a bidirectional spiral type, and this bidirectional spiral flow channel can provide a stronger lateral shear force so that the raw materials therein can be more uniform and complete when self-assembling to form an encapsulation layer, thereby effectively wrapping the nanosphere. In some embodiments, since the encapsulation reagents include multiple types, multiple different injection ports are set to inject these raw materials respectively. For example, the encapsulation inlet 110 includes a three-pronged first injection port 111, a second injection port 112, and a third injection port 113. The nanospheres are injected into the nucleic acid storage microfluidic chip 1 from the second injection port 112, and different encapsulation reagent raw materials are injected into the second injection port 112 and the third injection port 113 at the same time, and then fully mixed in the encapsulation channel 120.
[0074] refer to Figure 1 In some embodiments, the nucleic acid storage microfluidic chip 1 further includes an encapsulation layer removal unit 200. The encapsulation layer removal unit 200 includes a decapsulation inlet 210, a decapsulation channel 220, and a decapsulation outlet 230 that are connected in sequence. The encapsulated nanospheres obtained after the encapsulation by the encapsulation layer generation unit 100 can be put into another encapsulation container for storage after the encapsulation outlet 130 is completed, or the encapsulation outlet 130 is directly connected to the decapsulation inlet 210 and introduced into the encapsulation layer removal unit 200 for decapsulation, or the pre-sorted part of the encapsulated nanospheres are re-injected into the decapsulation inlet 210 to remove the encapsulation layer on the surface for data reading. Similar to the encapsulation layer generation unit 100, considering that there may be more than one decapsulation reagent, the decapsulation inlet 210 can also be provided with a plurality of different injection ports to respectively inject different decapsulation reagent raw materials, for example, the decapsulation inlet 210 includes a trident-shaped fourth injection port 211, a fifth injection port 212, and a sixth injection port 213. In some specific implementations, the de-encapsulation channel 220 adopts a folded serpentine channel. Through this structural setting, the chip length is greatly saved while lengthening the reaction channel and ensuring that the encapsulation layer is completely removed.
[0075] refer to Figure 1In some embodiments, the nucleic acid storage microfluidic chip also includes a nucleic acid extraction unit 300. The nucleic acid extraction unit 300 includes an extraction inlet 310, an extraction flow channel 320 and an extraction outlet 330 that are connected in sequence. After the decapsulation is completed, the nanospheres directly enter the nucleic acid extraction unit 300 from the extraction inlet 310, and the extraction reagent injected through the extraction inlet 310 denatures the nucleic acid fragments on the surface of the nanospheres so as to free at least a part of them, and then recovers the nucleic acid data and the mixed solution of the nanospheres from the extraction outlet 330, and the supernatant is taken by centrifugation and the like to complete the extraction of the nucleic acid data. The extracted nucleic acid data is further sequenced, for example, NGS sequencing, nanopore sequencing and the like can be used to complete the reading of the nucleic acid fragment data. Among them, the template used for the second-generation sequencing is usually the product of the amplification of the original nucleic acid fragments, so in the embodiments of the present application, it is also necessary to amplify the extracted nucleic acid fragments by methods such as PCR.
[0076] The embodiment of the present application also provides a method for encapsulating nucleic acids, which comprises reacting an organic ligand, a metal ion and a nanosphere to generate an encapsulation layer composed of a metal organic framework, thereby completing the encapsulation of the nanosphere. The encapsulation method involves a nanosphere, on the surface of which at least one nucleic acid fragment is fixed. In this way, an encapsulation layer of a metal organic framework is formed on the surface of the nanosphere, and the nucleic acid fragment fixed on the surface of the nanosphere is encapsulated and protected.
[0077] The present application also provides a method for decapsulating nucleic acid, wherein the decapsulation method comprises mixing the encapsulated nanospheres with a decapsulation agent to react and thereby remove the encapsulation layer on the surface of the nanospheres to obtain decapsulated nanospheres. The degradable properties of the metal organic framework material are utilized to destroy its coordination bonds and release the nanospheres from the encapsulation layer, so that the nucleic acid fragments fixed thereon can be further processed.
[0078] The embodiment of the present application also provides a method for extracting nucleic acid, which reacts the nanoballs after removing the encapsulation layer with an extraction reagent to free at least part of the nucleic acid fragments on the nanoballs from the nanoballs to complete the extraction. The single-stranded DNA is obtained by removing the encapsulation layer and chemically denaturing, and then amplified by PCR and other methods for high-throughput sequencing. After sequencing, the sequence is decoded to obtain data information, and the remaining single-stranded DNA on the nanoball as the master can be annealed and extended by polymerase reaction to restore the original data, realizing a closed DNA data storage chain of write-read-recovery, and can perform multiple lossless reads, avoiding the damage caused by the whole library access based on the PCR method.
[0079] The present application is described below with reference to specific embodiments:
[0080] Example 1
[0081] This embodiment provides a nucleic acid storage microfluidic chip. The nucleic acid storage microfluidic chip 1 has the multifunctional integration of generating a packaging layer, removing a packaging layer and acquiring DNA data.
[0082] refer to Figure 1 The nucleic acid storage microfluidic chip 1 includes an encapsulation layer generating unit 100, an encapsulation layer removing unit 200 and a nucleic acid extracting unit 300. The encapsulation layer generating unit 100 includes an encapsulation inlet 110, an encapsulation flow channel 120 and an encapsulation outlet 130 which are interconnected. The encapsulation inlet 110 includes three parallel three-pronged first injection ports 111, second injection ports 112 and third injection ports 113. The encapsulation flow channel 120 is two connected bidirectional spiral flow channels, wherein the bidirectional spiral flow channel refers to two reverse spiral flow channel portions connected, in which one spiral flow channel portion flows clockwise and in the other spiral flow channel portion flows counterclockwise. The encapsulation layer removing unit 200 includes a de-encapsulation inlet 210, a de-encapsulation flow channel 220 and a de-encapsulation outlet 230. The de-encapsulation inlet 210 includes three parallel three-pronged fourth injection ports 211, fifth injection ports 212 and sixth injection ports 213. The de-encapsulation flow channel 220 is a serpentine flow channel structure that continuously turns back. The nucleic acid extraction part 300 includes an extraction inlet 310, an extraction channel 320 and an extraction outlet 330 which are interconnected. The extraction inlet 310 is directly connected to the decapsulation outlet 230 and is provided with two opposite seventh injection ports 311 and eighth injection ports 312. The structure of the extraction channel 320 is the same as that of the encapsulation channel 120.
[0083] The overall length H of the microfluidic chip is 92mm, the width W is 24mm, the flow channel width d is 1.2mm, and the flow channel height is 0.06mm. Among them, the length of the encapsulation flow channel 120 in the encapsulation layer generating unit 100 is 103mm, and its repeated bidirectional spiral flow channel can effectively mix the reaction reagents fully, thereby forming a fully wrapped encapsulation layer on the surface of the nanosphere, and the encapsulated nanospheres can flow out through the encapsulation outlet 130 to the separately arranged sealing tube for freeze-drying and storage for storage. When it is necessary to access and read the DNA data on the nucleic acid fragments in the encapsulated nanospheres, all valves in the encapsulation layer generating unit 100 (not shown in the figure) are closed, and the aqueous solution is added to the sealing tube for vortex mixing, and then pumped to the encapsulation layer removal unit 200. The length of the de-encapsulation flow channel 220 of the encapsulation layer removal unit 200 is 62mm, and its folded serpentine structure is arranged to lengthen the reaction flow channel, which can greatly save the overall length of the chip. The length of the extraction channel 320 of the nucleic acid extraction part 300 is 99 mm, and the structure is the same as that of the encapsulation channel 120, and is also a bidirectional spiral type, so that the nucleic acid fragments on the surface of the nanospheres can fully react with the extraction reagent and be separated from the surface of the nanospheres. The nucleic acid fragments freed from the nanospheres and the mixed solution of the nanospheres are recovered at the extraction outlet 330, and the extraction is completed by centrifugation or the like.
[0084] Example 2
[0085] This embodiment provides a DNA packaging method, which uses the nucleic acid storage microfluidic chip provided in Example 1 for packaging, and does not use the microfluidic chip for packaging outside the chip.
[0086] This embodiment relates to a nanosphere having at least one nucleic acid fragment fixed on its surface. The preparation method of the nanosphere is as follows:
[0087] 1. Amplify the single-stranded DNA encoding the data information into a double-stranded DNA using primers (one of which has an amino group modified at the 5′ end).
[0088] Amplify the DNA oligos pool (0.5 ng / μL) by PCR using the following primer pairs:
[0089] CTTTCCCTACACGACGCTCT(SEQ ID No.1);
[0090] TCTGCACACGAGAAGGCTAG (5′ terminal amino group modified) (SEQ ID No. 2);
[0091] The PCR reaction system is:
[0092]
[0093] The PCR reaction procedure is as follows:
[0094] (1) 95°C, 2 min;
[0095] (2) 95°C, 30 s;
[0096] (3) 58°C, 20 s;
[0097] (4) 72°C, 15 s;
[0098] Repeat (2)-(4) 30 times to complete the amplification.
[0099] The product was purified using PureLink PCR kit (Invitrogen) to obtain amino-modified double-stranded DNA.
[0100] The DNA oligos library in this example includes 3210 single-stranded nucleotides, each nucleotide is 140 nt long, and 10 of them are exemplified below:
[0101] CTTTCCCTACACGACGCTCTAAGAAAGGGAAGGAAAGTCATTCGAACCGCTAACTTGACGAAGATTCAAAGACGGAGCCGGACAACCGCCACGCTTACCTCGGGTAAGGCATTCTCTGCCCTAGCCTTCTCGTGTGCAGA(SEQID No.3);
[0102] CTTTCCCTACACGACGCTCTCCCAACCAATACCAAACCAAACCGGGCTGCCCGCCAGCGGATCTGAGATAGTTTCTTGCGCAAGATAGGCGGTACATATTGTGATACCTTCCTATAGAGTCTAGCCTTCTCGTGTGCAGA(SEQID No.4);
[0103] CTTTCCCTACACGACGCTCTCCAACCAATACCTACCAGTTATAGCCAGTAAGGAGGGACGCTGGTTAAGTTACCATAGACATTAAATCGTTTAGGTAGGAGCACCGGCCTATCGTTGGTACTAGCCTTCTCGTGTGCAGA(SEQID No.5);
[0104] CTTTCCCTACACGACGCTCTGGAAGGACGAGTGAGGTGGATCTTCGAGCTAACGACGGACCTGTTGGCACTGAACTACGTCATCCGTGACGAACTTGCCAGTGTGCGAACATGAGGCTTTCTAGCCTTCTCGTGTGCAGA(SEQID No.6);
[0105] CTTTCCCTACACGACGCTCTGAAGGACGAGTTGGAGTGCCGTGTGACTGGAGAAGTCTATGTTCACAGAGTCTCTCCGATGAATAAAGTCGGCGCCGAACGGCGGGTGAAGAGACAGATCCTAGCCTTCTCGTGTGCAGA(SEQID No.7);
[0106] CTTTCCCTACACGACGCTCTGGACGAGTTTAAAGAATACGTATGGATTGTGTAAAGTCATTTCTCGCAACGGTCCTAGATTGACCGCAGATCTACTGACGCCCTTGTACGGGACTGTGTACTAGCCTTCTCGTGTGCAGA (SEQ ID No. 8);
[0107] CTTTCCCTACACGACGCTCTAATACCTTGAAGTCACACCTCGTCCCACTTAAGAGCGAAATCCTTTATCGGAGATGACTTAGACGTCGCGGTACTAGGTTACGCGGCAGCGGGACATGATCTAGCCTTCTCGTGTGCAGA (SEQ ID No. 9);
[0108] CTTTCCCTACACGACGCTCTACGAGTTTAACCGGAGGATAACGTGGTGAGGGTCGTGAGTACCGAGTGACTTCATGTTAGTCTTAACCGGTTCTATTTCATCCGACGCGTTAAACACCTCCTAGCCTTCTCGTGTGCAGA (SEQ ID No. 10);
[0109] CTTTCCCTACACGACGCTCTCGAGTTTAACCGGAGACTTCGAGGCTCGACATTCGCCTCCCTCGGGTGATATCCACGTTCGCCCTAGTATTTAGCTTTGTGAATCGAACTTACTGCCGAGCTAGCCTTCTCGTGTGCAGA (SEQ ID No. 11);
[0110] CTTTCCCTACACGACGCTCTGAGTTTAACCGGTGCCTATAATAGAGAAGAGGAGTCATGCTGTAGGGTCGTACAATTTCGATCGACAATAGTCATTGTCGGGCTGCAGCACTCACAATGACTAGCCTTCTCGTGTGCAGA (SEQ ID No. 12).
[0111] 2. The double-stranded DNA obtained in step 1 is coupled to the surface of carboxylated silica microspheres to obtain nanospheres with at least one nucleic acid fragment fixed on the surface.
[0112] Among them, carboxylated silica microspheres were purchased from Xi'an Ruixi Biotechnology Co., Ltd. with a concentration of 25 mg / mL and a size of 500 nm.
[0113] The coupling method is as follows:
[0114] (1) Take 100 μL of carboxylated silica microspheres into a 1.5 mL eppendorf tube, centrifuge at 8000 g for 5 min, and carefully discard the supernatant with a pipette; then resuspend with 1 mL of activation buffer (sodium acetate solution, 10 mM, pH 5.4) and wash once by centrifugation (8000 g, 5 min), and carefully discard the supernatant with a pipette; then resuspend with 100 μL of activation buffer (sodium acetate solution, 10 mM, pH 5.4) and vortex thoroughly for 10 min; then quickly add 50 μL of freshly prepared EDC solution (100 mg / mL) and 50 μL of freshly prepared NHS solution (50 mg / mL) and vortex to mix, and incubate slowly at room temperature for 30 min with tilting rotation; after incubation, the sample is washed three times by centrifugation with activation buffer (8000 g, 5 min), and resuspended in 100 μL of activation buffer.
[0115] (2) The amino-modified double-stranded DNA amplified and purified in step 1 (diluted to 0.0069-6.94 μM with 100 μL activation buffer) was added to the activated silica ball solution and incubated at room temperature for 30 min with slow tilt rotation. After incubation, the solution was washed by centrifugation three times (8000 g, 5 min) using 1×TE buffer (pH=7.4), and finally resuspended in 100 μL 1×TE buffer (pH=7.4) and stored at -20°C for later use to obtain nanospheres with at least one nucleic acid fragment fixed on the surface.
[0116] The packaging method outside the chip is:
[0117] (1) Prepare encapsulation reagent I (aqueous solution of 2-methylimidazole, 160 mM), take 250 μL and add it to a 1.5 mL centrifuge tube containing nanospheres and vortex mix, which is called mixed solution I;
[0118] (2) Prepare encapsulation reagent II (aqueous solution of anhydrous zinc acetate, 40 mM), and take 250 μL of it and pump it into mixed solution I at a speed of 30 μL / min using an air pump positive pressure injection method. During the pumping process, the centrifuge tube is kept vortexed.
[0119] The packaging method within the chip is:
[0120] (1) Prepare encapsulation reagent I (aqueous solution of 2-methylimidazole, 160 mM), take 250 μL and add it to a 1.5 mL centrifuge tube containing nanospheres and vortex mix, which is called mixed solution I;
[0121] (2) Prepare encapsulation reagent II (aqueous solution of anhydrous zinc acetate, 40 mM) and transfer 250 μL into a 1.5 mL centrifuge tube;
[0122] (3) The mixed solution I is pumped into the nucleic acid storage microfluidic chip 1 from the second injection port 112 at a speed of 30 μL / min by means of an air pump positive pressure injection mode, and the encapsulation reagent II is pumped into the nucleic acid storage microfluidic chip 1 from the first injection port 111 at a speed of 30 μL / min by means of an air pump positive pressure injection mode. The encapsulated nanospheres flow out at the encapsulation outlet 130.
[0123] The morphology of the nanospheres obtained by encapsulation in the above two ways is as follows Figure 2 As shown, A is a nanosphere obtained by off-chip packaging, and B is a nanosphere obtained by packaging using the nucleic acid storage microfluidic chip of Example 1. Compared with the two, the encapsulation layer generated in the chip is more uniform and there is no independent nucleation on the surface. This is because under the action of lateral shear, the mixing of the bidirectional spiral flow channel in the chip is more intense and uniform, thereby generating a uniform encapsulation layer, showing the unique advantages of the chip with spiral structure flow channel, especially bidirectional spiral flow channel, in synthesizing the encapsulation layer. Figure 2 C is the particle diameter of the nanospheres before and after encapsulation using the microfluidic chip. By comparing the diameters of the two, the thickness of the generated encapsulation layer is about 24 nm. In addition, when the microfluidic chip of Example 1 is used for encapsulation, the entire process can be completed within 10 minutes.
[0124] Example 3
[0125] This embodiment provides a method for decapsulation and extraction using the nucleic acid storage microfluidic chip of embodiment 1, the steps are as follows:
[0126] (1) Prepare decapsulation reagent III (citrate buffer, pH 4.5), and take 100 μL and pump it into the fourth injection port 211. At the same time, pump 100 μL of encapsulated nanospheres implemented according to the chip encapsulation method in Example 2 into the fifth injection port 212. Both are pumped into the chip at the same speed of 40 μL / min by positive pressure injection.
[0127] (2) Take 100 μL of extraction reagent (sodium hydroxide, 450 mM) and pump it into the seventh injection port 311 at a speed of 40 μL / min using positive pressure injection. The encapsulation layer can be removed and the DNA data can be extracted within 5 minutes.
[0128] Figure 3A to C are electron microscope images of the nanospheres before encapsulation, after encapsulation, and after the encapsulation layer is removed. Comparing A and B, there is a uniform ZIF-8 encapsulation layer on the surface of the nanospheres after encapsulation; comparing B and C, after the surface encapsulation layer of the nanospheres is removed, the original silicon sphere morphology is exposed.
[0129] Example 4
[0130] The nanospheres encapsulated in the chip encapsulation method in Example 2 were irradiated with a UV box (UV A, UV B and UV C lamps were turned on at the same time) for 0, 2, 4 and 8 hours, and then the encapsulation layer was removed and DNA data was extracted in the manner of Example 3. The DNA concentration was quantitatively analyzed using real-time fluorescent polymerase chain reaction (qPCR). The results showed that the DNA nanospheres protected by the encapsulation layer ZIF-8 were reduced to about 75% relative to the initial concentration. Under the same UV irradiation treatment conditions, the naked DNA was not encapsulated and protected, and the DNA concentration dropped to about 15% relative to the initial concentration, and the digital information could no longer be restored. The results are as follows Figure 4 As shown in A.
[0131] The above-mentioned ultraviolet irradiation was replaced with copper-catalyzed free radical treatment. The qPCR results showed that the final DNA concentration of the DNA nanospheres protected by the encapsulation layer ZIF-8 was reduced to about 75% relative to the initial concentration, while the naked DNA concentration was reduced to less than 15%.
[0132] In summary, using ZIF-8 as an encapsulation protective layer can effectively protect DNA from damage by ultraviolet rays and free radicals to a certain extent.
[0133] Example 5
[0134] This example is used to illustrate how to access DNA data fixed on the surface of nanospheres without loss. Generally, after the DNA with data is directly encapsulated and protected, when the DNA data needs to be accessed, the protection layer needs to be removed as a whole, and then all the DNA needs to be extracted for PCR amplification and sequencing to read the data. Multiple PCR amplifications will lead to the accumulation of PCR bias, which will eventually lead to incomplete DNA data information.
[0135] To ensure the integrity of the data, in this scheme, the single-stranded DNA encoding the data is amplified into a double-stranded DNA by primers (one of the primers is amino-modified at the 5′ end), coupled to the surface of the carboxylated silica nanospheres by amide bonds, and then encapsulated for protection. Figure 5As shown in A, the encapsulation layer is removed through the chip, and a single-stranded DNA is obtained by chemical denaturation, and then high-throughput sequencing is performed after PCR amplification. The sequence after sequencing can obtain data information after decoding. The remaining single-stranded DNA on the mother silicon nanosphere is annealed and extended by polymerase reaction to restore the original data, realizing a closed DNA data storage chain of write-read-restore, and can be read without loss multiple times, avoiding the damage caused by accessing the entire library based on the PCR method.
[0136] In addition, the particle size and internal fluorescence of surface carboxylated silica nanospheres can be used as parameters for selective access. For example, nanospheres with specific parameters can be sorted out by flow cytometry, and then the encapsulation layer can be removed and data extracted by microfluidic chips. Therefore, nanospheres can be used as a fixed substrate for index reading and data copying.
[0137] Based on the above principle, the nanospheres after removal of the encapsulation layer and extraction in Example 3 were recovered and restored to double strands through polymerase reaction. The encapsulation-decapsulation-extraction method in the chip of Examples 2 and 3 was repeated 10 times, and the qPCR quantitative curve of the extracted DNA single strand was shown in the figure. Figure 5 As shown in B, it can be seen from the figure that the number of molecules of the DNA single strand extracted in 10 visits is basically the same, so lossless reading can be performed.
[0138] Example 6
[0139] This embodiment provides a method for encapsulating nucleic acid, which is different from the encapsulation method in the chip in Example 2 in that encapsulation reagent I is a 50 mM 2-formyl imidazole solution, and encapsulation reagent II is a 10 mM zinc nitrate solution, forming an encapsulation layer composed of ZIF-90.
[0140] Example 7
[0141] This embodiment provides a method for packaging nucleic acid, which is different from the packaging method in the chip in Example 2 in that packaging agent I is a 500mM 2-methylimidazole solution, and packaging agent II is a 100mM cobalt nitrate solution, forming a packaging layer composed of ZIF-67.
[0142] The encapsulation effect of DNA nanospheres in Examples 6 and 7 is similar to the on-chip encapsulation method in Example 2, and will not be described in detail here.
[0143] The present application is described in detail above in conjunction with the embodiments, but the present application is not limited to the above embodiments, and various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present application. In addition, the embodiments of the present application and the features in the embodiments can be combined with each other without conflict. SEQUENCE LISTING <110> Southern University of Science and Technology <120> Nucleic acid encapsulation and decapsulation method and nucleic acid storage microfluidic chip <130> 1 <160> 12 <170> PatentIn version 3.5 <210> 1 <211> 20 <212> DNA <213> Artificial sequence <400> 1 ctttccctac acgacgctct 20 <210> 2 <211> 20 <212> DNA <213> Artificial sequence <400> 2 tctgcacacg agaaggctag 20 <210> 3 <211> 140 <212> DNA <213> Artificial sequence <400> 3 ctttccctac acgacgctct aagaaaggga aggaaagtca ttcgaaccgc taacttgacg 60 aagattcaaa gacggagccg gacaaccgcc acgcttacct cgggtaaggc attctctgcc 120 ctagccttct cgtgtgcaga 140 <210> 4 <211> 140 <212> DNA <213> Artificial sequence <400> 4 ctttccctac acgacgctct cccaaccaat accaaaccaa accgggctgc ccgccagcgg 60 atctgagata gtttcttgcg caagataggc ggtacatatt gtgatacctt cctatagagt 120 ctagccttct cgtgtgcaga 140 <210> 5 <211> 140 <212> DNA <213> Artificial Sequence <400> 5 ctttccctac acgacgctct ccaaccaata cctaccagtt atagccagta aggagggacg 60 ctggttaagt taccatagac attaaatcgt ttaggtagga gcaccggcct atcgttggta 120 ctagccttct cgtgtgcaga 140 <210> 6 <211> 140 <212> DNA <213> Artificial Sequence <400> 6 ctttccctac acgacgctct ggaaggacga gtgaggtgga tcttcgagct aacgacggac 60 ctgttggcac tgaactacgt catccgtgac gaacttgcca gtgtgcgaac atgaggcttt 120 ctagccttct cgtgtgcaga 140 <210> 7 <211> 140 <212> DNA <213> Artificial Sequence <400> 7 ctttccctac acgacgctct gaaggacgag ttggagtgcc gtgtgactgg agaagtctat 60 gttcacagag tctctccgat gaataaagtc ggcgccgaac ggcgggtgaa gagacagatc 120 ctagccttct cgtgtgcaga 140 <210> 8 <211> 140 <212> DNA <213> Artificial sequence <400> 8 ctttccctac acgacgctct ggacgagttt aaagaatacg tatggattgt gtaaagtcat 60 ttctcgcaac ggtcctagat tgaccgcaga tctactgacg cccttgtacg ggactgtgta 120 ctagccttct cgtgtgcaga 140 <210> 9 <211> 140 <212> DNA <213> Artificial sequence <400> 9 ctttccctac acgacgctct aataccttga agtcacacct cgtcccactt aagagcgaaa 60 tcctttatcg gagatgactt agacgtcgcg gtactaggtt acgcggcagc gggacatgat 120 ctagccttct cgtgtgcaga 140 <210> 10 <211> 140 <212> DNA <213> Artificial sequence <400> 10 ctttccctac acgacgctct acgagtttaa ccggaggata acgtggtgag ggtcgtgagt 60 accgagtgac ttcatgttag tcttaaccgg ttctatttca tccgacgcgt taaacacctc 120 ctagccttct cgtgtgcaga 140 <210> 11 <211> 140 <212> DNA <213> Artificial sequence <400> 11 ctttccctac acgacgctct cgagtttaac cggagacttc gaggctcgac attcgcctcc 60 ctcgggtgat atccacgttc gccctagtat ttagctttgt gaatcgaact tactgccgag 120 ctagccttct cgtgtgcaga 140 <210> 12 <211> 140 <212> DNA <213> Artificial sequence <400> 12 ctttccctac acgacgctct gagtttaacc ggtgcctata atagagaaga ggagtcatgc 60 tgtagggtcg tacaatttcg atcgacaata gtcattgtcg ggctgcagca ctcacaatga 120 ctagccttct cgtgtgcaga 140
Claims
1. A method for encapsulating nucleic acid, characterized in that: The method comprises the following steps: distributing an organic ligand, a metal ion and a nanosphere having at least one nucleic acid fragment fixed on the surface thereof in a bidirectional spiral microchannel for mixed reaction, wherein the organic ligand and the metal ion react to generate a metal organic framework and form an encapsulation layer on the surface of the nanosphere to obtain an encapsulated nanosphere; The bidirectional spiral microchannel is composed of two spiral channel parts connected in opposite directions, wherein the flow is clockwise in one of the spiral channel parts and counterclockwise in the other spiral channel part.
2. The packaging method according to claim 1, characterized in that: The metal ions are transition metal ions, the organic ligands are imidazole ligands, and the metal organic frameworks are ZIFs.
3. The packaging method according to claim 2, characterized in that: The transition metal ion is selected from at least one of zinc ion and cobalt ion.
4. The packaging method according to claim 2, characterized in that: The imidazole ligand is selected from at least one of imidazole, 2-methylimidazole, 2-ethylimidazole, 2-nitroimidazole, 2-formylimidazole, 4,5-dichloroimidazole, benzimidazole and 5-chlorobenzimidazole.
5. The packaging method according to claim 2, characterized in that: The imidazole ligand is 2-methylimidazole, and the transition metal ion is zinc ion.
6. The packaging method according to claim 1, characterized in that: The nucleic acid fragment is fixed to the nanosphere by any one of electrostatic adsorption, chemical bonding, and biotin-avidin binding.
7. Encapsulated nanospheres obtained according to the encapsulation method according to any one of claims 1 to 6.
8. A method for decapsulating nucleic acid, characterized in that: The following steps are involved: The encapsulation reagent is mixed with the encapsulated nanospheres according to claim 7 to react, and the encapsulation layer is removed to obtain the decapsulated nanospheres.
9. The decapsulation method according to claim 8, characterized in that: The decapsulation reagent is an acidic reagent.
10. The decapsulation method according to claim 9, characterized in that: The acidic reagent is an acidic buffer; 11. The decapsulation method according to claim 9, characterized in that: The acidic reagent is a citrate buffer solution, and the pH of the citrate buffer solution is less than 7.
12. The decapsulation method according to claim 11, characterized in that: The pH of the citrate buffer solution is 4-5.
13. Use of the encapsulated nanospheres according to claim 7 in DNA data storage and reading.
